Explained: Azithromycin, out of favour as Covid-19 therapy - News Summed Up

Explained: Azithromycin, out of favour as Covid-19 therapy


The authors of the new study have said that if azithromycin does not have a role in the treatment of Covid-19, avoiding its use would reduce unnecessary antibiotic consumption. (Wikimedia Commons)At one stage, azithromycin was the most commonly prescribed outpatient therapy for Covid-19. Now, a new study has shown that it does not have a role in the treatment of Covid-19; it only has a placebo effect. Having been shown to reduce exacerbations in chronic airway diseases, it was widely prescribed for Covid-19 initially, including in India. Overuse concernsThe authors of the new study have said that if azithromycin does not have a role in the treatment of Covid-19, avoiding its use would reduce unnecessary antibiotic consumption.


Source: Indian Express July 22, 2021 22:51 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */